BRD4 and neoplasm: In contrast, the combination of the bioorthogonal NPs (PED + N3@PGDA7) and PDT dramatically regressed 95% of tumour growth, which was 1.5-fold more efficient than BRD4 degradation alone caused by PED + N3@PGDA7 treatment.